[ASAP] Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00084

Source: ACS Medicinal Chemistry Letters - June 30, 2022 Category: Chemistry Authors: Santo Previti, Roberta Ettari, Elsa Calcaterra, Carla Di Chio, Rahul Ravichandran, Collin Zimmer, Stefan Hammerschmidt, Annika Wagner, Marta Bogacz, Sandro Cosconati, Tanja Schirmeister, and Maria Zappala ̀ Source Type: research